Nuvalent advances cancer drug trials, maintains strong cash position By Investing.com

Published on 27 Feb 2024 on Investing.com

Nuvalent advances cancer drug trials, maintains strong cash position

Read the rest of the article

Start tracking your investments with Statfolio

We recently published a list of Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks. In thi...

Insider Monkey · via Yahoo Finance 20 Jan 2025

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. ...

Insider Monkey · via Yahoo Finance 22 Sep 2024

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In t...

Insider Monkey · via Yahoo Finance 22 Sep 2024

Investors are always looking for stocks that are poised to beat at earnings season and Nuvalent, ...

Zacks via Yahoo Finance 6 May 2024

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 5 Apr 2024

Few corners of the market have been as prone to dealmaking over the last couple of years as the l...

Investing.com 4 Apr 2024

Nuvalent, Inc. ( NASDAQ :NUVL) Director Matthew Shair has recently sold a significant amount of t...

Investing.com 2 Apr 2024

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 30 Mar 2024

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 25 Mar 2024

Nuvalent Inc (NASDAQ:NUVL), a company specializing in the development of precisely targeted thera...

GuruFocus.com via Yahoo Finance 19 Mar 2024